Reorganização da assistência à saúde da mulher na prevenção do Câncer Cérvico - uterino: uma proposta de intervenção

Abstract

This paper presents a reorganization proposal for the Womens Health Care in the prevention of cervical cancer in the Health Center Centro de Saúde Diamante, regional Barreiro from Belo Horizonte. The cervical cancer is considered a public health problem in Brazil. Worldwide is the second leading cause of cancer death in women, and in Brazil is the second most frequent cancer in women. The main strategy for early detection / screening of cervical cancer is the cervicovaginal cytopathological examination and microflora, popularly known as Papanicolaou Smear. The Ministry of Health recommends that the cythopathological examination should be performed on 25 to 60 year-old women who have had sexual intercourse. The recommendation is to take the exam once a year, and every three years after two consecutive negative annual results. It is estimated that about 40% of Brazilian women have never been subjected to such tests. A data survey was conducted at the Centro de Saúde Diamante, where it was found that only 4.73% of the 25 to 60 year-old female population had an updated preventive examination. The aim of this paper is to propose strategies to increase the coverage of this preventive examination among 25 to 60 year-old women in the scope of this Health Centre. The literature review was performed by reading articles from the databases LILACS, BIREME, and SCIELO and from publications of the Ministry of Health. It was evident that poor adherence is related to difficulty of access to the examination and to obstacles that women faced, such as shame, fear, misinformation, lack of gynecological complaints. Strategies for the reorganization of the services and improvement of Womens Care, educational activities for the population and training of health professionals are proposed. It is hoped that the proposed actions increase the coverage of the preventive examination and reduce the incidence and mortality from cervical cancer.